What is the primary purpose of this 8-K filing?

This 8-K filing announces a material definitive agreement: CVS Corporation's entry into an Agreement and Plan of Merger with Caremark Rx, Inc. It details the terms of the proposed merger, where CVS will acquire Caremark.

How will Caremark shareholders be compensated in the merger?

Caremark shareholders will receive 1.670 shares of CVS common stock for each share of Caremark common stock they own at the effective time of the merger. This is an all-stock transaction.

What are the key conditions required for the merger to be completed?

The merger is subject to several conditions, including approval by the common stockholders of both CVS and Caremark, expiration of the Hart-Scott-Rodino Act waiting period and other regulatory approvals, accuracy of representations and warranties, and the performance of obligations by both parties. Counsel opinions on tax-free reorganization status are also required.

Will the management or board structure change as a result of the merger?

Yes, upon the effective time of the merger, the board of directors of the combined company will be split evenly between individuals who were directors of CVS and Caremark prior to the merger.

CVS 8-K: Material Agreements

Summary

CVS Corporation (CVS) has announced a significant strategic move with the filing of this 8-K report on November 2, 2006. The primary focus of this filing is the execution of an Agreement and Plan of Merger with Caremark Rx, Inc. (Caremark). This transaction will see CVS acquire Caremark through a merger, with Caremark becoming a wholly owned subsidiary of CVS. The deal is structured as a stock-for-stock transaction, where Caremark shareholders will receive 1.670 shares of CVS common stock for each share of Caremark common stock they hold.

Key Highlights

1CVS Corporation to acquire Caremark Rx, Inc. via merger.
2The transaction is an all-stock deal, with Caremark shareholders receiving 1.670 shares of CVS common stock per Caremark share.
3Caremark will become a wholly owned subsidiary of CVS upon completion of the merger.
4The combined entity's board of directors will be evenly split between former CVS and Caremark directors.
5Customary representations, warranties, and covenants are included in the Merger Agreement.
6Conditions for closing the merger include shareholder approvals, regulatory clearances (including HSR Act), and accuracy of representations.
7Both CVS and Caremark boards are expected to recommend the transaction to their respective shareholders.

CVS HEALTH Corp 8-K Report, Material Agreement (Nov 2, 2006)

Summary

Key Highlights

Frequently Asked Questions